Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Government Prohibits...

    Government Prohibits Stent companies to withdraw stents for Next Six Months

    Written by Ruby Khatun Khatun Published On 2017-04-25T15:12:29+05:30  |  Updated On 14 Aug 2021 12:03 PM IST

    New Delhi: In a bid to prevent Multinational Stent makers from removing their next generation stents from the Indian Market, the central government has invoked special clauses to Prohibits Stent companies to withdraw stents for now


    TOI reports that the government through National Pharmaceutical Pricing Authority (NPPA) has invoked special powers under the law to prohibit stent makers from withdrawing their products from the market for the next six months and directed them to maintain production, import and supply of coronary stents to avoid any shortage.


    The Department of Pharmaceuticals (DoP) said that it had come across reports regarding shortage of coronary stents in the market and in hospitals.


    After due deliberations on the current situation and the alternatives available with the government to resume normal supply of the coronary stents, power of Section 3(i) of the Drugs Price Control Order has been invoked which empowers the government to direct companies to maintain or increase production in case of emergency, or in circumstances of urgency or in case of non-commercial use in public interest.


    In addition to this the companies have also been directed to submit a weekly report on coronary stents produced and distributed, along with the production plan for the next week to the NPPA and the Drugs Controller General of India (DCGI).


    Sources informed TOI similar letters had been sent to all stent manufacturers.The DoP said that for the time being the order would be valid for the next six months, and its withdrawal or extension shall only be considered before the expiry of the period.


    In February, National Pharmaceutical Pricing Authority (NPPA), India's drug price regulator had capped prices of bare metal stents at Rs 7,260, whereas MRP of both drug eluting stents (DES) and biodegradable stents were fixed at Rs 29,600.


    Besides capping the MRP, the regulator had also imposed stringent norms on trade margins, discounts and other offers that companies often used to push sales of their products, particularly the high-end expensive ones.


    As a result, Abbott, Medtronics and including many multinational stent makers have sought to pull out their premium dissolvable stents from the country citing "unviability" and"commercial unsustainability" as reason for the same.


    It is learnt that other multinational companies besides Abbott and Medtronic are also contemplating similar moves seeking to withdraw some of their premium stents


    Read Also: After Abbott, two more Stent makers seek withdrawal of New Gen Stents

    Abbottbare metal stentsBiodegradable stentsDCGIDrug Eluting StentsDrugs Controller General of IndiaMedtronicsNational Pharmaceutical Pricing AuthorityNPPAStent
    Source : with inputs

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok